Table 5.
Input variables and cost estimates for inappropriate manoeuvres (1999 dollars)
| Variable | Value and Rangea | Source |
| D Manoeuvres | ||
| Blood Glucose Screening | ||
| Difference in eligible patients not screened | 4709 (2329,7089) | (36) |
| Specificity of blood glucose test | 89% | (3) |
| Cost of fasting glucose test | $10.34 | (57) |
| Cost of glucose tolerance test | $23.26 | (57) |
| Cost of HgA1c | $19.12 | (57) |
| PSA Testing | ||
| Difference in eligible patients not screened | 95 (-932, 1122) | (36) |
| Cost of PSA Test | $25 | (57) |
| Specificity of PSA test | 40% | (3) |
| Cost of Biopsy* | $232.83 | (58) |
| Mammography 40 to 49 | ||
| Difference in eligible patients not screened | 295 (-296, 887) | (36) |
| Cost of mammogram | $76.54 | (57) |
| Incidence of breast cancer | .001616 | (42) |
| Specificity of mammogram | 96.5% | (3) |
| Cost of Biopsy | $2,164 | (42) |
| Chest X-Ray | ||
| Difference in eligible patients not screened | 276 (-271, 822) | (36) |
| Cost of chest x-ray | $233 | (40) |
| Urine Proteinuria Screening | ||
| Difference in eligible patients not screened | 9947 (7934,11961) | (36) |
| Specificity of urine dipstick test | 95% | (3) |
| Cost of Urine culture and urinalysis | $27.18 | (57) |
a 95% Confidence Intervals
*Includes intracavitary ultrasonography, ultrasound guidance of biopsy and needle biopsy of the prostate